| __timestamp | Merck & Co., Inc. | Viridian Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 11606000000 | 7751000 |
| Thursday, January 1, 2015 | 10313000000 | 10251000 |
| Friday, January 1, 2016 | 9762000000 | 9575000 |
| Sunday, January 1, 2017 | 9830000000 | 10912000 |
| Monday, January 1, 2018 | 10102000000 | 11049000 |
| Tuesday, January 1, 2019 | 10615000000 | 11646000 |
| Wednesday, January 1, 2020 | 8955000000 | 13265000 |
| Friday, January 1, 2021 | 9634000000 | 25805000 |
| Saturday, January 1, 2022 | 10042000000 | 35182000 |
| Sunday, January 1, 2023 | 10504000000 | 94999000 |
Unlocking the unknown
In the competitive world of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for profitability. Over the past decade, Merck & Co., Inc. and Viridian Therapeutics, Inc. have taken different paths in optimizing these costs.
Merck, a giant in the industry, has consistently maintained SG&A expenses around $10 billion annually, with a slight decrease of about 10% from 2014 to 2020. This stability reflects Merck's strategic cost management amidst fluctuating market conditions.
In contrast, Viridian, a smaller player, has seen its SG&A expenses skyrocket by over 1,100% from 2014 to 2023, indicating aggressive expansion and investment in growth.
This comparison highlights the diverse strategies companies employ in managing operational costs, with Merck focusing on efficiency and Viridian on growth. Understanding these strategies provides valuable insights into their long-term business models.
Operational Costs Compared: SG&A Analysis of Eli Lilly and Company and Merck & Co., Inc.
SG&A Efficiency Analysis: Comparing Merck & Co., Inc. and Novartis AG
Merck & Co., Inc. vs Regeneron Pharmaceuticals, Inc.: SG&A Expense Trends
Comparing SG&A Expenses: Merck & Co., Inc. vs Merus N.V. Trends and Insights
Operational Costs Compared: SG&A Analysis of Merck & Co., Inc. and Geron Corporation
Who Optimizes SG&A Costs Better? Merck & Co., Inc. or Iovance Biotherapeutics, Inc.
Comparing SG&A Expenses: Merck & Co., Inc. vs Evotec SE Trends and Insights
Selling, General, and Administrative Costs: Vertex Pharmaceuticals Incorporated vs Viridian Therapeutics, Inc.
Comparing SG&A Expenses: Sarepta Therapeutics, Inc. vs Viridian Therapeutics, Inc. Trends and Insights
Comparing SG&A Expenses: Alpine Immune Sciences, Inc. vs Viridian Therapeutics, Inc. Trends and Insights
Breaking Down SG&A Expenses: Veracyte, Inc. vs Viridian Therapeutics, Inc.
BioCryst Pharmaceuticals, Inc. or Viridian Therapeutics, Inc.: Who Manages SG&A Costs Better?